| Secondary |
| Product Used For Unknown Indication |
58.3% |
| Atrial Fibrillation |
25.0% |
| Eczema |
8.3% |
| Hypothyroidism |
8.3% |
|
| Congenital Genitourinary Abnormality |
42.9% |
| Spinal Epidural Haemorrhage |
28.6% |
| Urinary Tract Infection |
14.3% |
| Urticaria |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
11.0% |
| Primary Hypothyroidism |
9.5% |
| Hypertension |
8.5% |
| Hypothyroidism |
8.3% |
| Acth Decreased |
6.2% |
| Blood Follicle Stimulating Hormone Decreased |
5.5% |
| Blood Luteinising Hormone Decreased |
5.5% |
| Blood Corticotrophin Decreased |
4.8% |
| Depression |
4.5% |
| Growth Hormone Deficiency |
4.5% |
| Blood Thyroid Stimulating Hormone Decreased |
3.9% |
| Follicle-stimulating Hormone Deficiency |
3.6% |
| Hypogonadism Female |
3.5% |
| Tsh Decreased |
3.3% |
| Angina Pectoris |
3.1% |
| Luteinising Hormone Deficiency |
3.0% |
| Oesophagitis |
3.0% |
| Asthma |
2.9% |
| Hypogonadism |
2.9% |
| Osteoporosis |
2.8% |
|
| Pneumonia |
11.4% |
| Gastric Disorder |
8.6% |
| Prostatic Disorder |
6.7% |
| Cardiac Disorder |
5.7% |
| Cholelithiasis |
5.7% |
| Renal Failure |
5.7% |
| Arthropathy |
4.8% |
| Renal Failure Acute |
4.8% |
| Syncope |
4.8% |
| Urticaria |
4.8% |
| Chest Pain |
3.8% |
| Dizziness |
3.8% |
| Gallbladder Disorder |
3.8% |
| Nasal Disorder |
3.8% |
| Respiratory Tract Infection |
3.8% |
| Stomatitis |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Vomiting |
3.8% |
| Weight Decreased |
3.8% |
| Back Disorder |
2.9% |
|
| Interacting |
| Atrial Fibrillation |
66.7% |
| Hypothyroidism |
33.3% |
|
| Spinal Epidural Haemorrhage |
50.0% |
| Hypoalbuminaemia |
25.0% |
| Therapeutic Response Increased |
25.0% |
|
